Arena BioWorks
| Founded | January 12, 2024 |
|---|---|
| Founder | Stuart Schreiber |
| Type | Private biomedical research institute |
| Purpose | Accelerating therapeutic development through integrated research and company creation |
| Headquarters | 399 Binney Street, Kendall Square, Cambridge, Massachusetts, United States |
Key people | Stuart Schreiber (CEO), Steve Pagliuca (Executive Chair), Tom Cahill (Managing Director) |
| Funding | $500 million (private) |
| Website | arenabio.works |
Arena BioWorks was a privately funded, for‑profit biomedical research institute in Kendall Square, Cambridge, Massachusetts. Launched in January, 2024, it sought to shorten the path from biological insight to therapeutic development by combining basic research and company creation under one roof. It closed in November 2025.